Bank of New York Mellon’s Fortress Biotech FBIO Stock Holding History

Bank of New York Mellon’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,830	Closed	-$7.97K	–	4323
2023 Q3	$7.97K	Sell	1,830 -3,324	-64%	-$22.8K	﹤0.01%	4310
2023 Q2	$42.5K	Sell	5,154 -24	-0.5%	-$237	﹤0.01%	4202
2023 Q1	$63.7K	Hold	5,178	–	–	﹤0.01%	4148
2022 Q4	$50.9K	Sell	5,178 -26	-0.5%	-$288	﹤0.01%	4234
2022 Q3	$67K	Hold	5,204	–	–	﹤0.01%	4276
2022 Q2	$66K	Sell	5,204 -11,595	-69%	-$172K	﹤0.01%	4303
2022 Q1	$343K	Buy	16,799 +523	+3%	+$14.3K	﹤0.01%	3937
2021 Q4	$610K	Buy	16,276 +254	+2%	+$11.3K	﹤0.01%	3669
2021 Q3	$774K	Buy	16,022 +958	+6%	+$46.8K	﹤0.01%	3553
2021 Q2	$807K	Sell	15,064 -248	-2%	-$15K	﹤0.01%	3543
2021 Q1	$811K	Sell	15,312 -1,580	-9%	-$89.1K	﹤0.01%	3451
2020 Q4	$803K	Buy	16,892 +2,329	+16%	+$101K	﹤0.01%	3373
2020 Q3	$883K	Buy	14,563 +593	+4%	+$30.2K	﹤0.01%	3199
2020 Q2	$562K	Buy	13,970 +8,604	+160%	+$320K	﹤0.01%	3418
2020 Q1	$152K	Sell	5,366 -61	-1%	-$2.02K	﹤0.01%	3804
2019 Q4	$209K	Buy	5,427 +2,986	+122%	+$76.7K	﹤0.01%	3904
2019 Q3	$52K	Sell	2,441 -1,813	-43%	-$42.6K	﹤0.01%	4114
2019 Q2	$96K	Sell	4,254 -1,849	-30%	-$47.5K	﹤0.01%	4036
2019 Q1	$163K	Sell	6,103 -30	-0.5%	-$787	﹤0.01%	3922
2018 Q4	$79K	Hold	6,133	–	–	﹤0.01%	3999
2018 Q3	$147K	Hold	6,133	–	–	﹤0.01%	3984
2018 Q2	$274K	Sell	6,133 -513	-8%	-$28.9K	﹤0.01%	3848
2018 Q1	$454K	Sell	6,646 -501	-7%	-$31.7K	﹤0.01%	3633
2017 Q4	$428K	Sell	7,147 -12	-0.2%	-$707	﹤0.01%	3672
2017 Q3	$474K	Sell	7,159 -16	-0.2%	-$1.08K	﹤0.01%	3608
2017 Q2	$511K	Sell	7,175 -162	-2%	-$9.57K	﹤0.01%	3587
2017 Q1	$408K	Buy	7,337 +344	+5%	+$15.4K	﹤0.01%	3637
2016 Q4	$284K	Sell	6,993 -1,508	-18%	-$56.4K	﹤0.01%	3799
2016 Q3	$378K	Sell	8,501 -1,373	-14%	-$58.4K	﹤0.01%	3665
2016 Q2	$398K	Buy	9,874 +5,502	+126%	+$256K	﹤0.01%	3631
2016 Q1	$203K	Hold	4,372	–	–	﹤0.01%	3784
2015 Q4	$183K	Buy	4,372 +1,679	+62%	+$70.4K	﹤0.01%	3887
2015 Q3	$105K	Buy	2,693 +2	+0.1%	+$93	﹤0.01%	4095
2015 Q2	$136K	Buy	2,691 +285	+12%	+$14.6K	﹤0.01%	3979
2015 Q1	$139K	Sell	2,406 -42	-2%	-$1.75K	﹤0.01%	3980
2014 Q4	$89K	Buy	2,448 +3	+0.1%	+$88	﹤0.01%	4073
2014 Q3	$77K	Hold	2,445	–	–	﹤0.01%	4108
2014 Q2	$63K	Sell	2,445 -6,099	-71%	-$161K	﹤0.01%	4052
2014 Q1	$254K	Sell	8,544 -30	-0.3%	-$1.17K	﹤0.01%	3784
2013 Q4	$339K	Buy	8,574 +838	+11%	+$32.4K	﹤0.01%	3711
2013 Q3	$813K	Buy	7,736 +1,129	+17%	+$138K	﹤0.01%	3348
2013 Q2	$852K	Buy	+6,607	New	+$974K	﹤0.01%	3273

Other funds holding FBIO

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of New York Mellon's FBIO Position: Q4 2023 in Review

Bank of New York Mellon sold out of Fortress Biotech (FBIO) in Q4 2023, closing a stake of 1,830 shares — an estimated $7.97K sold.

Bank of New York Mellon first reported a position in FBIO in Q2 2013 and held it in 42 quarters. The position peaked at $883K in Q3 2020. 42 funds tracked by Wall St. Rank hold FBIO as of Q4 2023.

Bank of New York Mellon reported no remaining Fortress Biotech position as of Q4 2023 after selling out during the quarter.
Bank of New York Mellon sold 1,830 Fortress Biotech shares in Q4 2023, an estimated $7.97K.
Bank of New York Mellon first reported a position in Fortress Biotech in Q2 2013 and held it in 42 quarters.
Bank of New York Mellon's Fortress Biotech position peaked at $883K in Q3 2020.
42 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2023.

Based on Bank of New York Mellon's 13F filing for Q4 2023, filed 29 Jan 2024.